acute coronary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 18 years or above; 2) Hospitalized due to acute coronary syndrome; (The term acute coronary syndrome (ACS) refers to any group of clinical symptoms compatible with acute myocardial ischemia and includes ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina (UA)). 3) Able and willing to provide written informed consent and to comply with the study.
Exclusion criteria
Exclusion criteria: 1) Cardiac shock; 2) Unstable heart failure; 3) Beta-agonist therapy on a continuous or intermittent basis; 4) Hypotension (BPII; 8) Suspected acute myocardial infarction with heart rate0.24 sec or systolic blood pressure <100mmHg; 9) Existing contraindication for metoprolol or allergic to metoprolol or any excipients; 10) Participation in another clinical study with an investigational product during the last 3 months; 11) Previous enrolment in the present study; 12) Subjects the investigator thinks not suitable for this study. E.g. cancer, increased risk of cardiogenic shock; 13) Inability to sign the informed consent form; 14) Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of patients achieving target dose at time of discharge.; | — |
Contacts
General Hospital of PLA